e-ISSN 2460-7991

Efficacy and safety of 5% imiquimod cream compared to 10% KOH solution for elimination of molluscum contagiosum lesions in adults

Font Size:  Small  Medium  Large

Efficacy and safety of 5% imiquimod cream compared to 10% KOH solution for elimination of molluscum contagiosum lesions in adults

Marsha Bianti, Agung Muhammad Rheza, Aninda Marina, Rizka Farah Hilma, Sarah Mahri, Rahadi Rihatmadja, Teffy Nuari

Abstract


 

Background: Molluscum contagiosum (MC) is a benign infection caused by the Molluscipox virus that most often affects children and sexually active adolescents. Various topical therapeutic options are available, however, no single intervention is convincingly effective. Potassium hydroxide (KOH) solution is widely used but its usefulness is hampered with adverse effects. Newer preparation, 5% imiquimod cream seems to be as, if not more, effective. However, it is not legally available yet in Indonesia.

Aim: To assess the efficacy and safety of 5% imiquimod cream in treating adult molluscum contagiosum.

Methods: Literature search was done through Pubmed, EBSCO, dan Cochrane databases. Inclusion criteria included articles in English, available in free full text and matched with the clinical question as well as providing the clinical outcome of papules clearance within 12 weeks.

Results: There were three articles found to be related to the clinical question and they were critically appraised for their validity, importance, and applicability.

Conclusion: Only two studies were valid and further assessed for their importance and applicability. In regards to importance, imiquimod has fewer side effects than KOH, yet it was not constantly shown to be superior to KOH in curing MC lesions. We conclude that KOH solution is the preferred treatment of MC in adults.

 

Keywords: imiquimod, KOH, molluscum contagiosum, safety, efficacy

 


Full Text: PDF

References


1.      Nguyen HP, Franz E, Stiegel KR, Hsu S, Tyring SK. Treatment of molluscum contagiosum in adult, pediatric, and immunodeficient populations. J Cutan Med Surg. 2014;18:299-306.

2.      Piggott C, Friedlander SF, Tom W. Poxvirus Infections. In: Goldsmith LA, Kats SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. (Eds.) Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill. 2012; 2:2417-20.

3.      Van der Wouden JC, van der Sande R, van Suijlekom-Smit LW, Berger M, Butler CC, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2009;4:CD004767.

4.      Van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit LW, Koning S. Interventions for cutaneous molluscum contagiosum (Review). Cochrane Database Syst Rev. 2017;5:CD004767.

5.      Seo SH, Chin HW, Jeong DW, Sung HW. An open, randomized, comparative clinical and histological study of imiquimod 5% cream vs. 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Ann Dermato. 2010;22:156-62

6.      Chatra N, Sukumar D, Bhat RM, et al. A comparative study of 10% KOH solution and 5% imiquimod cream for the treatment of Molluscum contangiosum in the pediatric age. Indian Dermatol Online J. 2015;6:75-80

7.      Metkar A, Pande S, Khopkar U. An open, non-randomized, comparative study of imiquimod 5% cream vs. 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Indian J Dermatol Venereol Leprol. 2008;74:614-8